Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VVOS - Vivos Therapeutics Inc


IEX Last Trade
2.77
-0.120   -4.332%

Share volume: 15,223
Last Updated: Fri 30 Aug 2024 08:44:51 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$2.89
-0.12
-4.15%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
0.18%
1 Month
24.31%
3 Months
38.97%
6 Months
-47.88%
1 Year
-56.83%
2 Year
-91.33%
Key data
Stock price
$2.77
P/E Ratio 
-0.77
DAY RANGE
N/A - N/A
EPS 
-$0.19
52 WEEK RANGE
$1.91 - $48.79
52 WEEK CHANGE
-$0.58
MARKET CAP 
9.218 M
YIELD 
N/A
SHARES OUTSTANDING 
3.401 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
-0.09
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$39,789
AVERAGE 30 VOLUME 
$59,538
Company detail
CEO:
Region: US
Website: vivoslife.com
Employees: 82
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

vivos therapeutics, inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (sdb) comprising mild-to-moderate obstructive sleep apnea (osa). the company's solutions cover proprietary alternatives for treating mild-to-moderate osa; craniofacial and anatomical anomalies that are associated with mild-to-moderate osa. its treatment for osa involves specially designed and customized oral appliances and treatment protocols. the company, through its vivos integrated healthcare network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate osa. vivos therapeutics, inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. it caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers,

Recent news